Rapid, Living Practice Points from ACP: Update on remdesivir use for hospitalized COVID-19 patients
PHILADELPHIA, Feb. 9, 2021 – In updated Rapid, Living Practice Points, the American College of Physicians (ACP) addresses emerging evidence regarding the effectiveness of remdesivir in hospitalized patients with COVID-19 and whether benefits and harms vary by symptom duration, disease severity, and treatment duration. The paper, developed by the Scientific Medical Policy Committee of the ACP, Should Remdesivir Be Used for the Treatment of Patients with COVID-19?